Cardiovascular Toxicity as a Result of Psychotropic Drugs (original) (raw)

Risk of cardiovascular disease in people taking psychotropic medication: a literature review

Danielle Roberts

British Journal of Mental Health Nursing, 2019

View PDFchevron_right

Cardiologic side effects of psychotropic drugs

Enrico Romagnoli

Journal of Geriatric Cardiology, 2012

View PDFchevron_right

Cardiovascular effects of psychotropic drugs

Robert Feinstein

Current problems in cardiology, 2002

View PDFchevron_right

Cardiometabolic effects of psychotropic medications

Oluchi Abosi

Hormone molecular biology and clinical investigation, 2018

View PDFchevron_right

Managing cardiovascular disease risk in patients treated with antipsychotics: a multidisciplinary approach

Aleksey Tentler

Journal of Multidisciplinary Healthcare, 2014

View PDFchevron_right

Effects of Psychotropic Drugs on Cardiovascular System

E. Timuçin Oral

Effects of Psychotropic …, 2007

View PDFchevron_right

Antipsychotic Polypharmacy-Related Cardiovascular Morbidity and Mortality: A Comprehensive Review

Amber Edinoff

Neurology International

View PDFchevron_right

Cardiovascular disease among severe mental illness and psychiatric medication

sileshi demelash

2017

View PDFchevron_right

Sudden cardiac death secondary to antidepressant and antipsychotic drugs

Charles Antzelevitch

Expert Opinion on Drug Safety, 2008

View PDFchevron_right

Cardiac drug-psychotropic drug update ☆ ☆ This work was funded by the Malcolm Gibbs Foundation, Inc., New York, NY, USA

Anwarul karim

General Hospital Psychiatry, 2002

View PDFchevron_right

Abnormal Electrocardiographic Effects of Tricyclic Antidepressants

iman fatima

Scientific Inquiry and Review

View PDFchevron_right

Association between antipsychotics and cardiovascular adverse events: A systematic review

Célio de Sousa-Rodrigues

Revista da Associação Médica Brasileira, 2017

View PDFchevron_right

Cardiovascular side-effects of antipsychotic drugs: The role of the autonomic nervous system

Ric Procyshyn

Pharmacology & Therapeutics, 2012

View PDFchevron_right

Antidepressant Therapies and the Cardiac Patient: A Review

David Shimm

Military Medicine, 1982

View PDFchevron_right

Cardiac adverse reactions associated with psychotropic drugs

François Girardin

Dialogues in Clinical Neuroscience, 2007

View PDFchevron_right

Cardiovascular risks of atypical antipsychotic drug treatment

Milou-daniel Drici

Pharmacoepidemiology and Drug Safety, 2007

View PDFchevron_right

Psychotropic medications and the risk of sudden cardiac death during an acute coronary event

Matti Isohanni

European Heart Journal, 2011

View PDFchevron_right

A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice

Robert Bodén

Neuropsychiatric Disease and Treatment, 2013

View PDFchevron_right

Sudden cardiac death and antipsychotics. Part 2: Monitoring and prevention

Alex J Mitchell

Advances in Psychiatric Treatment, 2006

View PDFchevron_right

Minimizing cardiovascular adverse effects of atypical antipsychotic drugs in patients with schizophrenia

Shiv Shankar

Cardiology research and practice, 2014

View PDFchevron_right

Mechanisms Underlying the Actions of Antidepressant and Antipsychotic Drugs That Cause Sudden Cardiac Arrest

Serge Sicouri

Arrhythmia & Electrophysiology Review

View PDFchevron_right

Psychotropic drugs and the ECG: focus on the QTc interval

Paul Goodnick

Expert Opinion on Pharmacotherapy, 2002

View PDFchevron_right

Antidepressants and cardiovascular adverse events: A narrative review

pouya nezafati

ARYA atherosclerosis, 2015

View PDFchevron_right

A systematic review of cardiovascular effects after atypical antipsychotic medication overdose

Jason Hoppe

The American Journal of Emergency Medicine, 2009

View PDFchevron_right

Atypical antipsychotics and oxidative cardiotoxicity: review of literature and future perspectives to prevent sudden cardiac death

Vittorio Fineschi

Journal of Geriatric Cardiology : JGC, 2021

View PDFchevron_right

Assessment of cardiovascular risk in an Italian psychiatric outpatient sample: A chart review of patients treated with second-generation antipsychotics

Rocco Amendolara

International journal of mental health nursing, 2018

View PDFchevron_right

Psychopharmacology: Cardiac Effects of Antipsychotic Medications

mariam fayek

Psychiatric Services, 2001

View PDFchevron_right

Cardiovascular considerations in antidepressant therapy: an evidence-based review

Mehdi Farokhnia

The journal of Tehran Heart Center, 2013

View PDFchevron_right

Cardiometabolic management in severe mental illness requiring an atypical antipsychotic

Allison Schmitz

Mental Health Clinician, 2017

View PDFchevron_right

Pharmacologic Treatment of Depression in Patients With Heart Disease

Marissa Miyazaki

Psychosomatic Medicine, 2005

View PDFchevron_right

Cardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of german-speaking countries between 1993 and 2010

Eckart Ruether

The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), 2014

View PDFchevron_right

Considerations for the use of antidepressants in patients with cardiovascular disease

Steven Roose

American Heart Journal, 2000

View PDFchevron_right

The association between antipsychotic agents and the risk of myocardial infarction: a systematic review

Ian Douglas

British Journal of Clinical Pharmacology, 2011

View PDFchevron_right